Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darigabat CO2 Challenge in Healthy Volunteers
NCT04592536Phase 1Completed
- Sponsor
- Cerevel Therapeutics
- Start
- Oct 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of darigabat in panic disorder (4 arms), sponsored by Cerevel Therapeutics. Primary endpoint: Panic Symptom List-IV Total Score at Day 8. Started Oct 2020; status: completed.
02
Drugs
darigabat
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT04592536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592536.